Impactiviti Daily 041310 posted on April 13, 2010***** TODAY’S NEWS Hugely encouraging results for Novartis' new experimental (oral) MS treatment - Novartis’ Gilena has delivered an impressive performance in a Phase III trial in patients …Continue Reading about Impactiviti Daily 041310 →